GLP1R and Obesity: Therefore, manipulation of gut microbiota composition to engineer a specific bacterial consortium or increase abundance of some dominant and beneficial bacteria wih a long lasting effect on the activity of PYY and GLP-1 to inhibit food intake in the interest of maintaining a desirable body weight may prove a viable obesity therapy.